Brain-only metastatic breast cancer is a distinct clinical entity characterised by favourable median overall survival time and a high rate of long-term survivors
Anna S. Berghoff(Medical University of Vienna), Matthias Preusser(Medical University of Vienna), Zsuzsanna Bagó-Horváth(Comprehensive Cancer Center Vienna), Guenther G. Steger(Mount Vernon Hospital), Rupert Bartsch(Universitätszahnklinik Wien), Karin Dieckmann(University of Vienna), Georg Widhalm(Medical University of Vienna), Christoph Zielinski(Vienna General Hospital), Christine Marosi(Medical University of Vienna), Aysegül Ilhan‐Mutlu(Medical University of Vienna), P. Birner(Comprehensive Cancer Center Vienna), Manuel Magerle(Comprehensive Cancer Center Vienna)
Cited by 30
Related Papers
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
|Nature Reviews Clinical Oncology|2020|1.9k
Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
|Journal of Clinical Oncology|2010|1.6k
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
|Neuro-Oncology|2020|1.1k